Yanai Shlomo
Insider CIK 1562645 · PLX Director · GRA Director · SGNT Director · PM Director · PRGO Director · XELA Director · AMRX Director · CBM Director · PDLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2026-05-07 | 2026-05-08 | 34,819 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2026-05-07 | 2026-05-08 | 34,819 | — | $0 | 320,804 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2026-05-06 | 2026-05-08 | 19,824 | — | $0 | 19,824 | SEC↗ |
| PM Philip Morris Internationa | A Award | 2026-05-06 | 2026-05-08 | 1,119 | $169.93 | $190.2K | 10,120 | SEC↗ |
| PM Philip Morris Internationa | A Award | 2025-05-07 | 2025-05-09 | 1,002 | $174.82 | $175.2K | 8,759 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2025-05-06 | 2025-05-08 | 34,819 | — | $0 | 34,819 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2025-05-05 | 2025-05-08 | 40,258 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2025-05-05 | 2025-05-08 | 40,258 | — | $0 | 285,985 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2024-05-10 | 2024-05-14 | 76,453 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2024-05-10 | 2024-05-14 | 76,453 | — | $0 | 245,727 | SEC↗ |
| PM Philip Morris Internationa | A Award | 2024-05-08 | 2024-05-10 | 1,789 | $97.84 | $175.0K | 7,501 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2024-05-02 | 2024-05-06 | 40,258 | — | $0 | 40,258 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2023-05-10 | 2023-05-11 | 80,128 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2023-05-10 | 2023-05-11 | 80,128 | — | $0 | 169,274 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2023-05-09 | 2023-05-11 | 76,453 | — | $0 | 76,453 | SEC↗ |
| PM Philip Morris Internationa | A Award | 2023-05-03 | 2023-05-05 | 1,812 | $96.58 | $175.0K | 5,506 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2022-05-09 | 2022-05-10 | 80,128 | — | $0 | 80,128 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2022-05-08 | 2022-05-10 | 35,406 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2022-05-08 | 2022-05-10 | 35,406 | — | $0 | 89,146 | SEC↗ |
| PM Philip Morris Internationa | A Award | 2022-05-04 | 2022-05-06 | 1,759 | $99.53 | $175.1K | 3,598 | SEC↗ |
| GRA W R GRACE & CO | D To issuer | 2021-09-22 | 2021-09-22 | 6,973 | — | $0 | 0 | SEC↗ |
| GRA W R GRACE & CO | A Award | 2021-05-11 | 2021-05-12 | 1,683 | — | $0 | 6,973 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2021-05-06 | 2021-05-07 | 46,218 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2021-05-06 | 2021-05-07 | 46,218 | — | $0 | 53,740 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2021-05-05 | 2021-05-07 | 35,406 | — | $0 | 35,406 | SEC↗ |
| PM Philip Morris Internationa | A Award | 2021-05-05 | 2021-05-07 | 1,839 | $95.18 | $175.0K | 1,839 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise deriv | 2020-12-15 | 2020-12-18 | 7,522 | — | $0 | 0 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | M Exercise | 2020-12-15 | 2020-12-18 | 7,522 | — | $0 | 7,522 | SEC↗ |
| GRA W R GRACE & CO | A Award | 2020-05-12 | 2020-05-14 | 2,280 | — | $0 | 5,290 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2020-05-05 | 2020-05-06 | 46,218 | — | $0 | 46,218 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-12-14 | 2019-12-17 | 7,522 | — | $0 | 7,522 | SEC↗ |
| AMRX Amneal Pharmaceuticals, In | A Award deriv | 2019-12-14 | 2019-12-17 | 28,506 | — | $0 | 28,506 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 1,613 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 1,577 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 2,140 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 3,863 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 6,371 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 2,766 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2019-12-04 | 2019-12-05 | 1,980 | — | $0 | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 6,371 | $12.90 | $82.2K | 21,857 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 1,980 | $53.70 | $106.3K | 33,030 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 2,766 | $40.06 | $110.8K | 35,796 | SEC↗ |
| CBM CAMBREX CORP | S Sale | 2019-12-04 | 2019-12-05 | 35,796 | $60.00 | $2.15M | 0 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 1,577 | $58.98 | $93.0K | 31,050 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 1,613 | $45.12 | $72.8K | 29,473 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 3,863 | $21.70 | $83.8K | 25,720 | SEC↗ |
| CBM CAMBREX CORP | M Exercise | 2019-12-04 | 2019-12-05 | 2,140 | $41.23 | $88.2K | 27,860 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-06-20 | 2019-06-24 | 126,050 | $3.00 | $378.1K | 126,050 | SEC↗ |
| GRA W R GRACE & CO | A Award | 2019-05-08 | 2019-05-09 | 1,532 | — | $0 | 3,010 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2019-04-24 | 2019-04-25 | 2,766 | — | $0 | 2,766 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2019-04-24 | 2019-04-25 | 2,247 | — | $0 | 15,486 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2018-06-08 | 2018-06-12 | 54,348 | $2.76 | $150.0K | 54,348 | SEC↗ |
| GRA W R GRACE & CO | A Award | 2018-05-09 | 2018-05-11 | 1,478 | — | $0 | 1,478 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2018-04-26 | 2018-04-30 | 1,980 | — | $0 | 1,980 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2018-04-26 | 2018-04-30 | 1,397 | — | $0 | 13,239 | SEC↗ |
| XELA Exela Technologies, Inc. | D To issuer | 2017-07-12 | 2017-07-14 | 29,500 | — | $0 | 20,500 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2017-04-27 | 2017-05-01 | 1,577 | — | $0 | 1,577 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2017-04-27 | 2017-05-01 | 1,187 | — | $0 | 11,842 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 2,228 | $21.75 | $48.5K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer deriv | 2016-08-29 | 2016-08-31 | 8,556 | $21.75 | $186.1K | 0 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | D To issuer | 2016-08-29 | 2016-08-31 | 742 | $21.75 | $16.1K | 0 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2016-05-19 | 2016-05-23 | 3,263 | — | $0 | 3,263 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise deriv | 2016-05-04 | 2016-05-06 | 924 | — | $0 | 0 | SEC↗ |
| PRGO PERRIGO Co plc | M Exercise | 2016-05-04 | 2016-05-06 | 924 | $95.70 | $88.4K | 924 | SEC↗ |
| PRGO PERRIGO Co plc | F Tax w/h | 2016-05-04 | 2016-05-06 | 481 | $95.70 | $46.0K | 443 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2016-04-21 | 2016-04-22 | 1,613 | — | $0 | 1,613 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2016-04-21 | 2016-04-22 | 1,330 | — | $0 | 10,655 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise deriv | 2016-04-15 | 2016-04-18 | 742 | — | $0 | 2,228 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | M Exercise | 2016-04-15 | 2016-04-18 | 742 | — | $0 | 742 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2016-02-22 | 2016-02-23 | 8,556 | — | $0 | 8,556 | SEC↗ |
| PRGO PERRIGO Co plc | A Award deriv | 2015-11-04 | 2015-11-06 | 924 | $162.29 | $150.0K | 924 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2015-04-30 | 2015-05-01 | 1,271 | — | $0 | 9,325 | SEC↗ |
| CBM CAMBREX CORP | A Award deriv | 2015-04-29 | 2015-05-01 | 2,140 | — | $0 | 2,140 | SEC↗ |
| SGNT Sagent Pharmaceuticals, In | A Award deriv | 2015-04-15 | 2015-04-17 | 2,970 | — | $0 | 2,970 | SEC↗ |
| PLX Protalix BioTherapeutics, | A Award deriv | 2014-07-24 | 2014-07-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2014-04-25 | 2014-04-28 | 2,403 | — | $0 | 8,054 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2014-04-24 | 2014-04-28 | 3,863 | — | $0 | 3,863 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2013-04-26 | 2013-04-29 | 3,956 | — | $0 | 5,651 | SEC↗ |
| CBM CAMBREX CORP | M Exercise deriv | 2013-04-25 | 2013-04-29 | 6,371 | — | $0 | 6,371 | SEC↗ |
| CBM CAMBREX CORP | A Award | 2012-11-28 | 2012-11-29 | 1,695 | — | $0 | 1,695 | SEC↗ |